Where is the live CopyMark page for USPTO serial 79032845?

The live record is at https://getcopymark.com/trademark/79032845. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns Serial No. 79032845?

According to the public USPTO record for serial number 79032845, the listed owner(s) include: Pharma Development Holding GmbH, Pharma Development Holding GmbH, Pharma Development Holding GmbH.

What is USPTO serial number 79032845?

Serial number 79032845 is the USPTO application identifier for the mark Serial No. 79032845. It is used to track examination, publication, and registration of this trademark.

What is the current status of Serial No. 79032845?

Serial No. 79032845 (79032845) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover Serial No. 79032845?

The public record lists International Classes: 005, 035, 036, 041, 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: Serial No. 79032845 Serial# 79032845 | status 404; last event DENC | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79032845?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Stachniak

Jennifer Stachniak Johnson, Marcou & Isaacs, LLC317A East Liberty StreetSavannah, GA 31401UNITED STATES

Goods and services

Class	Description	Status	First use
005	Medicaments and pharmaceutical preparations for treating oncological conditions, immunological conditions, dermatological conditions, internal diseases, conditions of the central nervous system (CNS), conditions of the cardiovascular system (CVS), and infections; pharmaceutical preparations, in which the active substance is transported and released in a targeted manner via oral, parenteral, or topical application for treating oncological conditions, immunological conditions, dermatological conditions, internal diseases, conditions of the central nervous system (CNS), conditions of the cardiovascular system (CVS), and infections; pharmaceutical preparations for the targeted release, distribution and interaction of pharmaceutical active substances in the body, in particular liposomes; diagnostic agents for medical purposes, in particular, biomarker	SECTION 70 - CANCELLED	—
035	Management consulting, in particular business and business organization consultancy in connection with the admission of pharmaceuticals and medical devices; business and business organization consultancy in connection with the admission of pharmaceuticals and medical devices; import and export of pharmaceuticals and medical devices; Wholesale ordering, wholesale distributorships, wholesale store services, and retail outlets, all in the field of pharmaceuticals; marketing for pharmaceuticals and medical devices	SECTION 70 - CANCELLED	—
036	Financing services and consultancy, in particular, in the development of pharmaceuticals and medical devices	SECTION 70 - CANCELLED	—
041	Educational services, namely, providing internal and external advanced education for physicians and clinical research personnel, namely, classes, seminars, and workshops in the fields of medical care, pharmaceuticals, and medical devices at an education information academy, and distribution of course literature therewith	SECTION 70 - CANCELLED	—
042	Scientific research on behalf of third parties; mission oriented scientific research in the field of pharmacological and clinical development of pharmaceuticals; services of a chemical and microbiological laboratory; development of pharmaceuticals on behalf of third parties; services of a pharmaceutical laboratory for scientific research, analysis and tests of pharmaceuticals; data analysis for scientific and technical purposes, namely, analysis of data from clinical trials of pharmaceuticals; and patent licensing; patent agent services in the field of pharmaceuticals and medical devices	SECTION 70 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Mar 3, 2017	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED	—
Mar 3, 2017	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Aug 22, 2016	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED	—
Aug 31, 2015	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 31, 2015	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Dec 4, 2014	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
May 1, 2014	NA75	NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED	—
May 1, 2014	C75A	REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.	—
May 1, 2014	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Mar 21, 2014	715F	REGISTERED - SEC. 71 & SEC. 15 FILED	—
Mar 21, 2014	ES75	TEAS SECTION 71 & 15 RECEIVED	—
Dec 22, 2012	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Jul 14, 2008	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Jul 14, 2008	FIMP	FINAL DISPOSITION PROCESSED	—
Jun 25, 2008	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Mar 25, 2008	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 8, 2008	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 26, 2007	CORR	CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED	—
Dec 19, 2007	NPUB	NOTICE OF PUBLICATION	—
Dec 4, 2007	CNEA	EXAMINERS AMENDMENT MAILED	—
Dec 3, 2007	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Dec 3, 2007	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Dec 3, 2007	XAEC	EXAMINER'S AMENDMENT ENTERED	—
Dec 3, 2007	CNEA	EXAMINERS AMENDMENT -WRITTEN	—
Nov 28, 2007	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Nov 28, 2007	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Nov 27, 2007	FAXX	FAX RECEIVED	—
Nov 14, 2007	DOCK	ASSIGNED TO EXAMINER	—
Oct 26, 2007	CRCV	CORRECTION TRANSACTION RECEIVED FROM IB	—
Jul 10, 2007	CNFR	FINAL REFUSAL MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 10, 2007	CNFR	FINAL REFUSAL WRITTEN	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 19, 2007	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Jun 19, 2007	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jun 19, 2007	ALIE	ASSIGNED TO LIE	—
Jun 4, 2007	MAIL	PAPER RECEIVED	—
Feb 8, 2007	RFNT	REFUSAL PROCESSED BY IB	—
Jan 20, 2007	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Jan 20, 2007	RFRR	REFUSAL PROCESSED BY MPU	—
Jan 18, 2007	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Jan 17, 2007	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2007	DOCK	ASSIGNED TO EXAMINER	—
Jan 5, 2007	NWAP	NEW APPLICATION ENTERED	—
Jan 4, 2007	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

Serial No. 79032845